Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 7
2011 5
2012 1
2013 1
2014 4
2015 3
2016 3
2017 2
2018 2
2019 4
2021 5
2022 4
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Seroprevalence study in humans and molecular detection in Rhipicephalus sanguineus ticks of severe fever with thrombocytopenia syndrome virus in Thailand.
Saba Villarroel PM, Chaiphongpachara T, Nurtop E, Laojun S, Pangpoo-Nga T, Songhong T, Supungul D, Baronti C, Thirion L, Leaungwutiwong P, de Lamballerie X, Missé D, Wichit S. Saba Villarroel PM, et al. Among authors: baronti c. Sci Rep. 2024 Jun 11;14(1):13397. doi: 10.1038/s41598-024-64242-x. Sci Rep. 2024. PMID: 38862576 Free PMC article.
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Driouich JS, Cochin M, Lingas G, Luciani L, Baronti C, Bernadin O, Gilles M, Villarroel PMS, Moureau G, Petit PR, Dupont A, Izopet J, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Nguyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Tine J, Basilua JM, Angoulvant D, Tardivon C, Blancho G, Martin-Blondel G, Yazdanpanah Y, Mentré F, Lévy V, Touret F, Guedj J, de Lamballerie X, Nougairède A. Driouich JS, et al. Among authors: baronti c. Biomed Pharmacother. 2024 Aug;177:116988. doi: 10.1016/j.biopha.2024.116988. Epub 2024 Jun 18. Biomed Pharmacother. 2024. PMID: 38897157 Free article.
Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals.
Charrel RN, Coutard B, Baronti C, Canard B, Nougairede A, Frangeul A, Morin B, Jamal S, Schmidt CL, Hilgenfeld R, Klempa B, de Lamballerie X. Charrel RN, et al. Among authors: baronti c. Antiviral Res. 2011 May;90(2):102-14. doi: 10.1016/j.antiviral.2011.02.009. Epub 2011 Feb 26. Antiviral Res. 2011. PMID: 21356244 Review.
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer.
Rebaudi F, De Franco F, Goda R, Obino V, Vita G, Baronti C, Iannone E, Pitto F, Massa B, Fenoglio D, Jandus C, Poggio F, Fregatti P, Melaiu O, Bozzo M, Candiani S, Papaccio F, Greppi M, Pesce S, Marcenaro E. Rebaudi F, et al. Among authors: baronti c. Cancer Treat Rev. 2024 Nov;130:102831. doi: 10.1016/j.ctrv.2024.102831. Epub 2024 Sep 24. Cancer Treat Rev. 2024. PMID: 39342797 Free article. Review.
Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants.
Coutant F, Touret F, Pin JJ, Alonzo M, Baronti C, Munier S, Attia M, de Lamballerie X, Ferry T, Miossec P. Coutant F, et al. Among authors: baronti c. Emerg Microbes Infect. 2024 Dec;13(1):2307510. doi: 10.1080/22221751.2024.2307510. Epub 2024 Jan 30. Emerg Microbes Infect. 2024. PMID: 38240255 Free PMC article.
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals.
Thébault S, Lejal N, Dogliani A, Donchet A, Urvoas A, Valerio-Lepiniec M, Lavie M, Baronti C, Touret F, Da Costa B, Bourgon C, Fraysse A, Saint-Albin-Deliot A, Morel J, Klonjkowski B, de Lamballerie X, Dubuisson J, Roussel A, Minard P, Le Poder S, Meunier N, Delmas B. Thébault S, et al. Among authors: baronti c. PLoS Pathog. 2022 Sep 6;18(9):e1010799. doi: 10.1371/journal.ppat.1010799. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36067253 Free PMC article.
Picornavirus non-structural proteins as targets for new anti-virals with broad activity.
Norder H, De Palma AM, Selisko B, Costenaro L, Papageorgiou N, Arnan C, Coutard B, Lantez V, De Lamballerie X, Baronti C, Solà M, Tan J, Neyts J, Canard B, Coll M, Gorbalenya AE, Hilgenfeld R. Norder H, et al. Among authors: baronti c. Antiviral Res. 2011 Mar;89(3):204-18. doi: 10.1016/j.antiviral.2010.12.007. Epub 2011 Jan 12. Antiviral Res. 2011. PMID: 21236302 Review.
Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M. Bollati M, et al. Among authors: baronti c. Antiviral Res. 2010 Aug;87(2):125-48. doi: 10.1016/j.antiviral.2009.11.009. Epub 2009 Nov 27. Antiviral Res. 2010. PMID: 19945487 Free PMC article. Review.
49 results